Myovant Sciences Statistics Share Statistics Myovant Sciences has 97.26M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 97.26M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 50.86M Failed to Deliver (FTD) Shares 1,096,604 FTD / Avg. Volume 100.51%
Short Selling Information The latest short interest is 8.39M, so 0% of the outstanding
shares have been sold short.
Short Interest 8.39M Short % of Shares Out n/a Short % of Float 16.78% Short Ratio (days to cover) 17.86
Valuation Ratios The PE ratio is -6.01 and the forward
PE ratio is null.
Myovant Sciences's PEG ratio is
0.28.
PE Ratio -6.01 Forward PE n/a PS Ratio 5.36 Forward PS n/a PB Ratio -2.62 P/FCF Ratio -4.59 PEG Ratio 0.28
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Myovant Sciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.95,
with a Debt / Equity ratio of -0.78.
Current Ratio 1.95 Quick Ratio 1.92 Debt / Equity -0.78 Debt / EBITDA -2 Debt / FCF -1.36 Interest Coverage -13.41
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $398.92K Profits Per Employee $-355.75K Employee Count 579 Asset Turnover 0.44 Inventory Turnover 6.8
Taxes Income Tax 5.05M Effective Tax Rate -2.51%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 2.15, so Myovant Sciences's
price volatility has been higher than the market average.
Beta 2.15 52-Week Price Change n/a 50-Day Moving Average 26.92 200-Day Moving Average 21.14 Relative Strength Index (RSI) 61.01 Average Volume (20 Days) 1,091,060
Income Statement In the last 12 months, Myovant Sciences had revenue of 230.97M
and earned -205.98M
in profits. Earnings per share was -2.22.
Revenue 230.97M Gross Profit 179.42M Operating Income -187.35M Net Income -205.98M EBITDA -183.89M EBIT -186.96M Earnings Per Share (EPS) -2.22
Full Income Statement Balance Sheet The company has 406.7M in cash and 367.89M in
debt, giving a net cash position of 38.81M.
Cash & Cash Equivalents 406.7M Total Debt 367.89M Net Cash 38.81M Retained Earnings -1.25B Total Assets 403.52M Working Capital 140.83M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -268.56M
and capital expenditures -974K, giving a free cash flow of -269.53M.
Operating Cash Flow -268.56M Capital Expenditures -974K Free Cash Flow -269.53M FCF Per Share -2.9
Full Cash Flow Statement Margins Gross margin is 77.68%, with operating and profit margins of -81.11% and -89.18%.
Gross Margin 77.68% Operating Margin -81.11% Pretax Margin -86.99% Profit Margin -89.18% EBITDA Margin -79.62% EBIT Margin -81.11% FCF Margin -116.7%
